Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
In 2019, the market size of Anti-obesity Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-obesity Drugs.
This report studies the global market size of Anti-obesity Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-obesity Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segment by Product Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segment by Application
Kids
Adults
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-obesity Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-obesity Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-obesity Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
In 2019, the market size of Anti-obesity Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-obesity Drugs.
This report studies the global market size of Anti-obesity Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-obesity Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Market Segment by Product Type
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Market Segment by Application
Kids
Adults
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-obesity Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-obesity Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-obesity Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-obesity Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Peripherally Acting Anti-obesity Drugs
1.3.3 Centrally Acting Anti-obesity Drugs
1.4 Market Segment by Application
1.4.1 Global Anti-obesity Drugs Market Share by Application (2019-2025)
1.4.2 Kids
1.4.3 Adults
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Drugs Market Size
2.1.1 Global Anti-obesity Drugs Revenue 2014-2025
2.1.2 Global Anti-obesity Drugs Sales 2014-2025
2.2 Anti-obesity Drugs Growth Rate by Regions
2.2.1 Global Anti-obesity Drugs Sales by Regions 2014-2019
2.2.2 Global Anti-obesity Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-obesity Drugs Sales by Manufacturers
3.1.1 Anti-obesity Drugs Sales by Manufacturers 2014-2019
3.1.2 Anti-obesity Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-obesity Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anti-obesity Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-obesity Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Anti-obesity Drugs Price by Manufacturers
3.4 Key Manufacturers Anti-obesity Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-obesity Drugs Market
3.6 Key Manufacturers Anti-obesity Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Peripherally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.1.2 Centrally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.2 Global Anti-obesity Drugs Sales Market Share by Type
4.3 Global Anti-obesity Drugs Revenue Market Share by Type
4.4 Anti-obesity Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-obesity Drugs Sales by Application
6 United States
6.1 United States Anti-obesity Drugs Breakdown Data by Company
6.2 United States Anti-obesity Drugs Breakdown Data by Type
6.3 United States Anti-obesity Drugs Breakdown Data by Application
7 European Union
7.1 European Union Anti-obesity Drugs Breakdown Data by Company
7.2 European Union Anti-obesity Drugs Breakdown Data by Type
7.3 European Union Anti-obesity Drugs Breakdown Data by Application
8 China
8.1 China Anti-obesity Drugs Breakdown Data by Company
8.2 China Anti-obesity Drugs Breakdown Data by Type
8.3 China Anti-obesity Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-obesity Drugs Breakdown Data by Company
9.2 Rest of World Anti-obesity Drugs Breakdown Data by Type
9.3 Rest of World Anti-obesity Drugs Breakdown Data by Application
9.4 Rest of World Anti-obesity Drugs Breakdown Data by Countries
9.4.1 Rest of World Anti-obesity Drugs Sales by Countries
9.4.2 Rest of World Anti-obesity Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.1.4 Anti-obesity Drugs Product Introduction
10.1.5 Merck Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.2.4 Anti-obesity Drugs Product Introduction
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.3.4 Anti-obesity Drugs Product Introduction
10.3.5 Pfizer Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.4.4 Anti-obesity Drugs Product Introduction
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.5.4 Anti-obesity Drugs Product Introduction
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.6.4 Anti-obesity Drugs Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.7.4 Anti-obesity Drugs Product Introduction
10.7.5 Orexigen Therapeutics Recent Development
10.8 Vivus
10.8.1 Vivus Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.8.4 Anti-obesity Drugs Product Introduction
10.8.5 Vivus Recent Development
10.9 Amylin
10.9.1 Amylin Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.9.4 Anti-obesity Drugs Product Introduction
10.9.5 Amylin Recent Development
10.10 Alizyme
10.10.1 Alizyme Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.10.4 Anti-obesity Drugs Product Introduction
10.10.5 Alizyme Recent Development
10.11 Boehringer Ingelheim
10.12 Eisai
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-obesity Drugs Sales Channels
11.2.2 Anti-obesity Drugs Distributors
11.3 Anti-obesity Drugs Customers
12 Market Forecast
12.1 Global Anti-obesity Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Anti-obesity Drugs Sales Forecast by Type
12.3 Global Anti-obesity Drugs Sales Forecast by Application
12.4 Anti-obesity Drugs Forecast by Regions
12.4.1 Global Anti-obesity Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-obesity Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-obesity Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Peripherally Acting Anti-obesity Drugs
1.3.3 Centrally Acting Anti-obesity Drugs
1.4 Market Segment by Application
1.4.1 Global Anti-obesity Drugs Market Share by Application (2019-2025)
1.4.2 Kids
1.4.3 Adults
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-obesity Drugs Market Size
2.1.1 Global Anti-obesity Drugs Revenue 2014-2025
2.1.2 Global Anti-obesity Drugs Sales 2014-2025
2.2 Anti-obesity Drugs Growth Rate by Regions
2.2.1 Global Anti-obesity Drugs Sales by Regions 2014-2019
2.2.2 Global Anti-obesity Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-obesity Drugs Sales by Manufacturers
3.1.1 Anti-obesity Drugs Sales by Manufacturers 2014-2019
3.1.2 Anti-obesity Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-obesity Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anti-obesity Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Anti-obesity Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Anti-obesity Drugs Price by Manufacturers
3.4 Key Manufacturers Anti-obesity Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-obesity Drugs Market
3.6 Key Manufacturers Anti-obesity Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Peripherally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.1.2 Centrally Acting Anti-obesity Drugs Sales and Revenue (2014-2019)
4.2 Global Anti-obesity Drugs Sales Market Share by Type
4.3 Global Anti-obesity Drugs Revenue Market Share by Type
4.4 Anti-obesity Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-obesity Drugs Sales by Application
6 United States
6.1 United States Anti-obesity Drugs Breakdown Data by Company
6.2 United States Anti-obesity Drugs Breakdown Data by Type
6.3 United States Anti-obesity Drugs Breakdown Data by Application
7 European Union
7.1 European Union Anti-obesity Drugs Breakdown Data by Company
7.2 European Union Anti-obesity Drugs Breakdown Data by Type
7.3 European Union Anti-obesity Drugs Breakdown Data by Application
8 China
8.1 China Anti-obesity Drugs Breakdown Data by Company
8.2 China Anti-obesity Drugs Breakdown Data by Type
8.3 China Anti-obesity Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-obesity Drugs Breakdown Data by Company
9.2 Rest of World Anti-obesity Drugs Breakdown Data by Type
9.3 Rest of World Anti-obesity Drugs Breakdown Data by Application
9.4 Rest of World Anti-obesity Drugs Breakdown Data by Countries
9.4.1 Rest of World Anti-obesity Drugs Sales by Countries
9.4.2 Rest of World Anti-obesity Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.1.4 Anti-obesity Drugs Product Introduction
10.1.5 Merck Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.2.4 Anti-obesity Drugs Product Introduction
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.3.4 Anti-obesity Drugs Product Introduction
10.3.5 Pfizer Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.4.4 Anti-obesity Drugs Product Introduction
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Roche
10.5.1 Roche Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.5.4 Anti-obesity Drugs Product Introduction
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.6.4 Anti-obesity Drugs Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.7.4 Anti-obesity Drugs Product Introduction
10.7.5 Orexigen Therapeutics Recent Development
10.8 Vivus
10.8.1 Vivus Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.8.4 Anti-obesity Drugs Product Introduction
10.8.5 Vivus Recent Development
10.9 Amylin
10.9.1 Amylin Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.9.4 Anti-obesity Drugs Product Introduction
10.9.5 Amylin Recent Development
10.10 Alizyme
10.10.1 Alizyme Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-obesity Drugs
10.10.4 Anti-obesity Drugs Product Introduction
10.10.5 Alizyme Recent Development
10.11 Boehringer Ingelheim
10.12 Eisai
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-obesity Drugs Sales Channels
11.2.2 Anti-obesity Drugs Distributors
11.3 Anti-obesity Drugs Customers
12 Market Forecast
12.1 Global Anti-obesity Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Anti-obesity Drugs Sales Forecast by Type
12.3 Global Anti-obesity Drugs Sales Forecast by Application
12.4 Anti-obesity Drugs Forecast by Regions
12.4.1 Global Anti-obesity Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-obesity Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
